Results 221 to 230 of about 114,692 (269)

Association between glucagon‐like peptide‐1 receptor agonist use and peri‐operative pulmonary aspiration: a systematic review and meta‐analysis

Anaesthesia, EarlyView.
Summary Introduction Glucagon‐like peptide‐1 receptor agonists are known to delay gastric emptying; however, the association between glucagon‐like peptide‐1 receptor agonist use and peri‐operative pulmonary aspiration risk is not known. This systematic review and meta‐analysis aimed to summarise the evidence on whether glucagon‐like peptide‐1 receptor ...
Jasmin Elkin, Siddharth Rele, Priya Sumithran, Michael Hii, Sharmala Thuraisingam, Tim Spelman, Tuong Phan, Peter Choong, Michelle Dowsey, Cade Shadbolt   +9 more
wiley   +1 more source

Metabolic rate and insulin-independent glucose uptake increase in a TDP-43^Q331K mouse model of amyotrophic lateral sclerosis. [PDF]

Heliyon
McDonald TS, Cui CS, Lerskiatiphanich T, Marallag J, Lee JD.   +4 more
europepmc   +1 more source

Glucagon-like peptide-1 and impaired counterregulatory responses to hypoglycemia in type 1 diabetes. [PDF]

World J Diabetes
Rocha GR, de Melo FF.
europepmc   +1 more source

Effects of glucagon‐like peptide 1 receptor agonists on testicular dysfunction: A systematic review and meta‐analysis

Andrology, EarlyView.
Abstract Background Hypogonadism and infertility are two conditions that are heavily affected by overweight and obesity in the male patient. Glucagon‐like peptide 1 agonists (GLP‐1RAs) are a recently introduced class of antidiabetic drugs with powerful weight‐loss effect; this may induce an indirect positive effect on the testicular function ...
Gianmaria Salvio, Alessandro Ciarloni, Nicola Ambo, Monia Bordoni, Michele Perrone, Silvia Rossi, Giancarlo Balercia   +6 more
wiley   +1 more source

Insulinoma Mimic: Tramadol-induced Hypoglycemia. [PDF]

JCEM Case Rep
O'Hara S, Hinshaw T, McKenzie M, Belcher V, McCoy I, Haider A.   +5 more
europepmc   +1 more source

Semaglutide and non‐arteritic anterior ischaemic optic neuropathy: Review and interpretation of reported association

Acta Ophthalmologica, EarlyView.
Abstract This review covers a seminal study of the relation between exposure to the glucagon‐like peptide 1 (GLP‐1) agonist semaglutide and incident non‐arteritic anterior ischaemic optic neuropathy (NAION) in a neuro‐ophthalmology clinic setting, subsequent studies in unselected populations, a meta‐analysis of clinical trials and pathophysiology ...
Abdullah Amini, Steffen Hamann, Michael Larsen   +2 more
wiley   +1 more source

Molecular Pharmacology of Glucagon-Like Peptide 1-Based Therapies in the Management of Type Two Diabetes Mellitus and Obesity. [PDF]

Integr Pharm Res Pract
Alzahrani AM, Alshobragi GA, Alshehri AM, Alzahrani MS, Alshehri HA, Alzhrani RM, Basudan S, Alkatheeri AA, Almutairi SA, Alzahrani YA.   +9 more
europepmc   +1 more source

LYSOSOMAL CHANGES IN RAT HEPATIC PARENCHYMAL CELLS AFTER GLUCAGON ADMINISTRATIONI

, 1974
Takuma Saito, Kazuo Ogawa
openalex   +2 more sources

Sex Differences in Body Composition and MASLD in Children With Overweight and Obesity

Acta Paediatrica, EarlyView.
ABSTRACT Aim To explore the relationships between body composition, indices of hepatic fibrosis, and sonographic evidence of hepatic steatosis in children with overweight and obesity. Methods One hundred and seventy individuals (age 12.7 ± 3.4 years, 38.2% boys) with overweight/obesity (BMI z‐score 2.02 ± 0.54) underwent bioelectrical impedance ...
Adi Uretzky, Eyal Cohen‐Sela, Michal Yackobovitch‐Gavan, Asaf Ben Simon, Eyas Midlij, Hussein Zaitoon, Ophir Borger, Hagar Interator, Achiya Z. Amir, Hadar Moran‐Lev, Avivit Brener, Yael Lebenthal   +11 more
wiley   +1 more source

Impact of Glucagon-like Peptide-1 Receptor Agonists on Mental Illness: Evidence from a Mendelian Randomization Study. [PDF]

Int J Mol Sci
Xiang L, Peng Y.
europepmc   +1 more source